{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(Suppl 2)"],"submitter":["Dung L"],"journal":["Annals of oncology : official journal of the European Society for Medical Oncology"],"pagination":["ii79-ii79"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984060"],"repository":["biostudies-literature"],"pubmed_title":["P-274Pembrolizumab for patients with previously treated, mismatch repair–deficient microsatellite instability–high advanced colorectal carcinoma: phase 2 KEYNOTE-164 study"],"pmcid":["PMC4984060"],"pubmed_authors":["Chloe A","Ruixue W","Luis D","Takayuki Y","Peter K","Elena E","Eric V","Ravit G","Dirk J","You K","Minori K","Thierry A","Hiroya T","Dung L","Hiroki H","Matthew B","Won K","Johanna B"],"additional_accession":[]},"is_claimable":false,"name":"P-274Pembrolizumab for patients with previously treated, mismatch repair–deficient microsatellite instability–high advanced colorectal carcinoma: phase 2 KEYNOTE-164 study","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Jun","modification":"2025-04-26T20:34:12.904Z","creation":"2025-04-06T16:26:17.19Z"},"accession":"S-EPMC4984060","cross_references":{}}